# ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer

> **NCT00436072** · PHASE1 · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 46 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** ZD6474
- **DRUG:** Cetuximab
- **DRUG:** Irinotecan

## Key facts

- **NCT ID:** NCT00436072
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2012-02
- **Final completion:** 2012-08
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2012-10-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00436072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00436072, "ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00436072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*